Capri Global Capital Ltd. moves to reshape its capital structure

Bottom line: The Rs 4,000 crore authorization is large relative to Capri Global’s standalone equity base, but it is not the same as disclosed leverage headroom. Against total equity of Rs 6,736.6 crore, the authorization equals 59.38% of equity, derived from Rs 4,000 crore divided by Rs 6,736.6 crore ^{[1] [2]}. If the entire amount were raised as incremental debt with equity unchanged, the reported debt-to-equity ratio of 3.1 would mechanically increase by about 0.59 turns to approximately 3.69 turns ^[3]. This is a scenario, not management’s stated post-raise leverage.

CRAR and leverage capacity

• The latest quarterly KPI shows a debt-to-equity ratio of 3.1 for Q1 FY27 ^[3].
• The CRAR figure explicitly reported in the cited material is 25.85% as of 31 March 2026, rather than for Q1 FY27 ^[4].
• Consequently, the precise regulatory or internal leverage headroom cannot be calculated from the disclosed figures alone. It would require the applicable CRAR threshold, risk-weighted assets, the debt/equity definition used by the company, and the eventual mix of debt versus capital instruments.
• The Rs 4,000 crore should therefore be read as a maximum fundraising authorization, not as Rs 4,000 crore of confirmed additional borrowing capacity. The approval is subject to regulatory and shareholder approvals and may be executed in tranches ^[5].

Intended debt-versus-equity allocation

No numerical allocation was stated. The authorization covers:

• Debt-based instruments: debt securities and external commercial borrowings.
• Equity-linked or equity instruments: equity shares, rights/preferential/QIP or public issuance routes, convertibles and warrants.
• Hybrid: FCCBs, which combine debt characteristics with potential equity conversion.

The filing states only that the securities may be issued in one or more tranches; it says the specific terms and conditions will be disclosed after finalization ^[1]. Therefore, the stated debt-versus-equity split is not disclosed, and the full Rs 4,000 crore should not be assumed to be debt-funded.

The Rs 4,000 crore authorization is sizeable: it equals approximately 55.5% of the latest reported consolidated net worth of Rs 7,203.48 crore and is 2x the Rs 2,000 crore QIP completed in Q1 FY26. This is an authorization ceiling, not yet a committed or fully priced fundraise. ^{[5] [4] [6]}

Tier-I versus Tier-II preference

No preference is specified. The board approval authorizes a broad menu comprising equity shares, debt securities, convertible securities, warrants, FCCBs and ECBs, through one or more tranches and issuance methods. It does not identify a target split between Tier-I and Tier-II capital, nor does it state that the full amount is intended to qualify as regulatory capital. ^[5]

The filing also says that the specific terms and additional issuance details will be provided after they are finalized. ^[1] Accordingly:

• Equity issuance would generally be the relevant route for strengthening core or Tier-I capital, subject to regulatory classification.
• Eligible subordinated or qualifying debt could support Tier-II capital, but the approval does not commit to such an instrument.
• Ordinary senior debt, FCCBs, ECBs or other securities cannot be treated as Tier-I or Tier-II capital without their final terms and regulatory eligibility being known.

The reported management ambition of reaching Rs 55,000 crore AUM by FY28 was cited separately from the board filing; the Rs 4,000 crore approval itself does not specify a capital mix or quantify the funding required to achieve that AUM target. ^[6] The key unresolved variable is therefore not the authorization size, but how much is ultimately raised as equity or qualifying regulatory capital versus debt funding.